NCT06969807View on ClinicalTrials.gov

Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 9, 2025

Primary Completion Date

May 15, 2026

Study Completion Date

May 15, 2028

Conditions
Diabetic Kidney Disease (DKD)
Interventions
DRUG

Amimestrocel

In the first month (day 1, 14, 28): 1×10E6 cells per kilogram. From the 8th to the 24th week (week 8, 12, 16, 20, 24): 1.5×10E6 cells per kilogram.

Trial Locations (6)

100010

RECRUITING

Beijing Hospital, Beijing

100029

RECRUITING

China-Japan Friendship Hospital, Beijing

100050

RECRUITING

Capital Medical University Affiliated Beijing Friendship Hospital, Beijing

100053

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

100853

RECRUITING

Chinese PLA General Hospital, Beijing

102218

NOT_YET_RECRUITING

Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER